Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Top Stories

Africans slam rich nations for blocking access to generic COVID vaccines

2021 03 12T144445Z 1 LYNXMPEH2B11F RTROPTP 4 HEALTH CORONAVIRUS KENYA - Global Banking | Finance

By Nita Bhalla

NAIROBI (Thomson Reuters Foundation) – Charities in Africa slammed rich nations on Thursday for blocking efforts to waive patents for COVID-19 vaccines, saying this would prolong the pandemic for years in poorer nations and push millions across the continent deeper into poverty.

More than 40 charities, including Amnesty International and Christian Aid, said Wednesday’s move by Western nations to prevent generic or other manufacturers making more vaccines in poorer nations was “an affront on people’s right to healthcare.”

Peter Kamalingin, Oxfam International’s Africa director, said sub-Saharan Africa – 14% of the global population – had received only 0.2% of 300 million vaccine doses administered worldwide.

“Ensuring every African can get a safe and effective COVID-19 vaccine … is the most effective way to save lives and livelihoods, keep our children in school, reduce unemployment rates and re-open our economies,” he told a news conference.

“Without it, gains made by African countries on issues of food security, democratic governance, gender justice and women’s rights will be reversed completely.”

Richer members of the World Trade Organization (WTO) blocked a push by some 80 developing countries – led by India and South Africa – to waive its Trade-Related Aspects of Intellectual Property (TRIPS) agreement rules on patents.

The move sent a message that African lives were less important than those of people in rich nations, Kamalingin said.

Countries such as the United States and Britain argue that protecting intellectual property rights encourages research and innovation, and that suspending those rights would not result in a sudden surge of vaccine supply.

Africa’s confirmed coronavirus caseload is almost 4 million, with more than 100,000 deaths, according to the Africa Centres for Disease Control and Prevention.

While Africa accounts for less than 4% of the 118 million cases and 2.6 million deaths recorded globally, health experts say a lack of testing and reliable data from many African nations means the true figures may be far higher.

The World Bank estimates that the new coronavirus crisis has already pushed 40 million people in sub-Saharan economies into extreme poverty, that is, living on less than $1.90 a day.

Africa needs equitable access to vaccines to prevent further lockdowns, job losses and school closures, said the charities, which included the Pan-African Fight Inequality Alliance and the East Africa Tax and Governance Network.

“Without the vaccine, the pandemic will be prolonged on the continent. Africa will be in a pandemic state for the next four or five years,” warned Mwanahamisi Singano, programme manager from the African Women’s Development and Communication Network.

“If we don’t have the vaccine, we are extending the pandemic phase and all the evil that we have seen come with it.”

Western nations have celebrated the COVAX facility – a World Health Organization (WHO) vaccine-sharing programme to aid developing nations – which has so far delivered approximately 2 million doses to a handful of African countries.

But the charities said COVAX was far from an acceptable solution as it would only result in 20% of the population in those countries being vaccinated by the end of the year.

(Reporting by Nita Bhalla @nitabhalla, Editing by Katy Migiro. Please credit the Thomson Reuters Foundation, the charitable arm of Thomson Reuters, that covers the lives of people around the world who struggle to live freely or fairly. Visit http://news.trust.org)

 

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post